Campbell & CO Investment Adviser LLC Innoviva, Inc. Transaction History

Campbell & CO Investment Adviser LLC

$1.24 Billion
Q4 2024

A detailed history of Campbell & CO Investment Adviser LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 50,022 shares of INVA stock, worth $899,395. This represents 0.07% of its overall portfolio holdings.

Number of Shares

50,022

Previous 17,584 184.47%

Holding current value

$899,395

Previous $339,000 155.75%

% of portfolio

0.07%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$17.35 - $20.32 $562,799 - $659,140	32,438 Added 184.47%	50,022 $867,000
Q3 2024 Nov 12, 2024	SELL	$16.33 - $20.04 $88,051 - $108,055	-5,392 Reduced 23.47%	17,584 $339,000
Q2 2024 Aug 13, 2024	SELL	$14.4 - $16.4 $2,001 - $2,279	-139 Reduced 0.6%	22,976 $376,000
Q1 2024 May 10, 2024	BUY	$14.56 - $16.78 $336,554 - $387,869	23,115 New	23,115 $352,000
Q3 2023 Nov 08, 2023	BUY	$12.37 - $13.89 $19,717 - $22,140	1,594 Added 11.01%	16,078 $208,000
Q2 2023 Aug 11, 2023	BUY	$11.39 - $13.72 $164,972 - $198,720	14,484 New	14,484 $184,000
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $240,554 - $280,919	-20,386 Reduced 27.31%	54,248 $718,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $562,411 - $737,287	48,442 Added 184.95%	74,634 $867,000
Q2 2022 Aug 09, 2022	SELL	$14.32 - $19.88 $143,128 - $198,700	-9,995 Reduced 27.62%	26,192 $387,000
Q1 2022 May 09, 2022	BUY	$15.39 - $20.25 $103,651 - $136,383	6,735 Added 22.87%	36,187 $700,000
Q4 2021 Feb 10, 2022	BUY	$15.91 - $18.72 $206,830 - $243,359	13,000 Added 79.02%	29,452 $508,000
Q3 2021 Nov 10, 2021	BUY	$13.06 - $17.24 $214,863 - $283,632	16,452 New	16,452 $275,000
Q3 2020 Oct 15, 2020	SELL	$10.33 - $14.49 $168,368 - $236,172	-16,299 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$11.49 - $15.26 $187,275 - $248,722	16,299 New	16,299 $228,000
Q3 2019 Oct 16, 2019	SELL	$10.05 - $14.55 $228,426 - $330,706	-22,729 Closed	0 $0
Q2 2019 Jul 10, 2019	SELL	$13.1 - $14.95 $267,004 - $304,710	-20,382 Reduced 47.28%	22,729 $331,000
Q1 2019 May 10, 2019	BUY	$13.69 - $20.06 $590,189 - $864,806	43,111 New	43,111 $605,000
Q3 2018 Nov 08, 2018	SELL	$13.63 - $15.7 $515,377 - $593,648	-37,812 Closed	0 $0
Q2 2018 Jul 13, 2018	BUY	$13.44 - $17.59 $221,760 - $290,235	16,500 Added 77.42%	37,812 $522,000
Q1 2018 May 04, 2018	BUY	$13.8 - $16.99 $46,920 - $57,765	3,400 Added 18.98%	21,312 $355,000
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $50,380 - $63,351	-4,295 Reduced 19.34%	17,912 $254,000
Q3 2017 Nov 13, 2017	BUY	$12.06 - $14.12 $267,816 - $313,562	22,207	22,207 $314,000

Others Institutions Holding INVA

# of Institutions

234

Shares Held

76M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.25B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Account

Campbell & CO Investment Adviser LLC Innoviva, Inc. Transaction History